SUMMIT CLINICAL RESEARCH, s. r. o.
ActiveKey figures
Key figures
2025Dividends
calculatedDistributed as dividends 819 024 € (100 % of distributable profit).
Summary: SUMMIT CLINICAL RESEARCH, s. r. o.
What kind of company is it?
SUMMIT CLINICAL RESEARCH, s. r. o. (IČO 45447128) is a limited liability company (s.r.o.). The company was incorporated in 2010 and has existed for 16 years. Registered office according to the register: Bratislava - mestská časť Nové Mesto. Main activity according to the Statistical Office: činnosti špeciálnej lekárskej praxe (SK NACE 8622). Size category by number of employees: 10–19 employees.
Who runs the company and who owns it?
The company has one statutory representative. According to the register, the company has one shareholder. The registered capital is 5 000 €.
How is the company doing financially?
Revenue for 2025 was 2 180 768 €, up 19,8 % on the previous year (1 819 767 €). From 2021 to 2025, revenue grew by an average of 32,0 % per year. This is the highest revenue in the reported years (2021–2025). Net profit for 2025 was 1 266 658 € (58,1 % of revenue). The company was profitable in all 5 reported years. Personnel costs for 2025 were 251 700 €. At the end of 2025 the company had total assets of 1 435 595 € and equity of 1 272 658 € (equity ratio 88,7 %).
Where does the data come from and how current is it?
Company and people data come from the Register of Legal Entities (Statistical Office SR, CC BY 4.0) and financial statements from the Register of Financial Statements (Ministry of Finance SR); icoprofil.sk updates them daily. Data as of 11. 11. 2026. Changes, averages and ratios are calculated by icoprofil.sk from open data and are not an official assessment.
Summary of annual reports2021–2025
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Revenue (net turnover) | 717 323 | 470 752 | 1 537 755 | 1 819 767 | 2 180 768 |
| Profit for the reporting year | 280 237 | 135 551 | 685 582 | 819 024 | 1 266 658 |
| Retained earnings of previous periods | 0 | 0 | 0 | 0 | 0 |
| Total assets | 342 107 | 407 358 | 1 134 692 | 947 075 | 1 435 595 |
| Total liabilities | 55 870 | 265 807 | 443 110 | 122 051 | 162 937 |
| Total equity | 286 237 | 141 551 | 691 582 | 825 024 | 1 272 658 |
| Calculated dividends | — | 280 237 | 135 551 | 685 582 | 819 024 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Documents in the Register of Financial Statements14
- 2025 Oznámenie o dátume schválenia účtovnej závierky · 1 pp.
- 2025 Úč POD · 12 pp.
- 2025 Úč POD
- 2024 Oznámenie o dátume schválenia účtovnej závierky · 1 pp.
- 2024 Úč POD · 12 pp.
- 2024 Úč POD
- 2024 Úč POD · 12 pp.
- 2024 Úč POD
- 2023 Oznámenie o dátume schválenia účtovnej závierky · 1 pp.
- 2023 Úč POD · 12 pp.
- 2023 Úč POD
- 2022 Oznámenie o dátume schválenia účtovnej závierky · 1 pp.
- 2022 Úč MUJ · 5 pp.
- 2022 Úč MUJ
Documents open directly on registeruz.sk (Ministry of Finance of the Slovak Republic).
Similar companies
- MUDr. Dagmar Štrocholcová, s.r.o. · Kysucké Nové Mesto
- Buršík s. r. o. · Považská Bystrica
- Pajmed s.r.o. Trebišov · Trebišov
- MEDIDIAB s. r. o. · Senec
- KORBAŠ, s. r. o. · Považská Bystrica
- Rozprávky s.r.o. · Košice
- NEUROGRAM s. r. o. · Bratislava
- VEDERE, spol. s r.o. · Nitra
- OrtoRei s.r.o. · Martin
- NEUROMED MB, s.r.o. · Fiľakovo